Cardiothoracic Related Complications of Anti-PD/PD-L1 Immunotherapy
Background: Anti-PD/PD-L1-targeted immunotherapy is associated with shockingly high rates of sustained clinical responses in patients with a variety of tumour types, despite the high prevalence of dermatological, gastrointestinal, and endocrine side effects. The hazards of pneumonitis and cardiotoxicity associated with
Read More